A protocol based treatment for debilitating fibrosing skin disorders with (anti-CD-20), rituximab
Latest Information Update: 23 Sep 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Circumscribed scleroderma; Eosinophilic fasciitis
- Focus Adverse reactions; Therapeutic Use
- 23 Sep 2014 New trial record